Trading Halt
Filed with ASX · · 2 pages · English
On 6ix: 6ix.com/news/trading-halt-267
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings CallTrading in the securities of Mayne Pharma Group Limited (‘MYX’) will be halted at the request of MYX, pending the release of an announcement by MYX. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of: • the commencement of normal trading on Tuesday, 25 November 2025; or • the release of the announcement to the market. MYX’s request for a trading halt is a
Mayne Pharma Group Ltd. on 6ix
Earlier from Mayne Pharma
- Pause in Trading
- Update on status of FIRB approval and second court hearing
- MYX Declaration of Unacceptable Circumstances and Orders
- Update on FIRB approval and Scheme
- MYX - Panel Conducts Proceedings and Makes Interim Orders
Later from Mayne Pharma
- Update on FIRB condition and scheme
- Mayne Pharma issues notice of intention to terminate the SID
- MYX receives purported termination notice from Cosette
- Mayne Pharma terminates Scheme Implementation Deed
- Termination of Proposed Acquisition of Mayne Pharma
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma